Pfizer
Conrad Kurowski has extensive experience in data science and biometrics within the pharmaceutical industry, currently serving as Manager, Data Scientist at Pfizer since May 2020, focusing on risk-based monitoring in clinical data sciences. Previous roles at Pfizer include Senior Associate Data Scientist and Associate Data Scientist, contributing to global biometrics and data management. Earlier experience includes an Undergraduate Research Assistant position at Loyola University Chicago, involved in plant evolutionary genetics research, and a Summer Oncology Intern role at Cardinal Bernardin Cancer Center, where research focused on proteins related to hepatocellular carcinoma. Conrad holds a Bachelor's degree in Bioinformatics and Computer Science from Loyola University Chicago, earned in 2020.
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.